Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
56,884,883
-
Share change
-
-7,961,874
-
Total reported value
-
$786,691,344
-
Put/Call ratio
-
118%
-
Price per share
-
$13.83
-
Number of holders
-
135
-
Value change
-
-$113,523,101
-
Number of buys
-
66
-
Number of sells
-
59
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2020
As of 31 Dec 2020 Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) had 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,884,883 shares of stock of the company.
Largest 10 holders included HealthCor Management, L.P., FMR LLC, NEA Management Company, LLC, ORBIMED ADVISORS LLC, PICTET ASSET MANAGEMENT LTD, Point72 Asset Management, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, Avidity Partners Management LP, Connor, Clark & Lunn Investment Management Ltd., and KINGDON CAPITAL MANAGEMENT, L.L.C..
This table shows 138 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.